These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

377 related articles for article (PubMed ID: 8473213)

  • 41. Special pesticide formulations. Veterinarians must follow EPA rules.
    J Am Vet Med Assoc; 2004 Aug; 225(4):490-1. PubMed ID: 15344349
    [No Abstract]   [Full Text] [Related]  

  • 42. [Veterinary dispensary law and drug regulations].
    Gessler M
    Tierarztl Prax; 1982; 10(1):1-10. PubMed ID: 7179234
    [No Abstract]   [Full Text] [Related]  

  • 43. FDA's regulation of prescription drug labeling: a role for implied preemption.
    Kendrick LC
    Food Drug Law J; 2007; 62(1):227-47. PubMed ID: 17444031
    [No Abstract]   [Full Text] [Related]  

  • 44. Proposals for increasing the availability of animal drugs for minor species and minor uses.
    Vemulapalli TH; Mansouri ME; Oeller MR; Wilmot LM; Vaughn SD
    J Am Vet Med Assoc; 1999 Jun; 214(11):1632-5. PubMed ID: 10363093
    [No Abstract]   [Full Text] [Related]  

  • 45. Has the Food and Drug Administration abused its authority in attempting to regulate veterinary compounding?
    Siegner AW
    J Am Vet Med Assoc; 1994 Jul; 205(2):243-7. PubMed ID: 7928589
    [No Abstract]   [Full Text] [Related]  

  • 46. Current position of the F&DA regarding veterinary drug and feed additive registration in the USA.
    Leaning WH
    J S Afr Vet Assoc; 1981 Mar; 52(1):51-6. PubMed ID: 7265103
    [No Abstract]   [Full Text] [Related]  

  • 47. Presumption of innocence: FDA's authority to regulate the specifics of prescription drug labeling and the preemption debate.
    Dorfman HL; Quinn VM; Brophy EA
    Food Drug Law J; 2006; 61(4):585-622. PubMed ID: 17180765
    [No Abstract]   [Full Text] [Related]  

  • 48. Extra-label drug use--veterinary practitioner views: food animals.
    Johnson DE
    J Am Vet Med Assoc; 1993 May; 202(10):1645-7;discussion 1654-8. PubMed ID: 8514573
    [No Abstract]   [Full Text] [Related]  

  • 49. Inappropriate advertising of dietary supplements.
    de Lemos ML
    N Engl J Med; 2003 May; 348(22):2255-6; author reply 2255-6. PubMed ID: 12774807
    [No Abstract]   [Full Text] [Related]  

  • 50. Making progress for how medicines are used in children.
    Taylor-Zapata P; Mattison DR
    Arch Pediatr Adolesc Med; 2007 Sep; 161(9):916; author reply 916-7. PubMed ID: 17768295
    [No Abstract]   [Full Text] [Related]  

  • 51. FDA perspectives on supplement use by patients on antithrombotic therapy.
    Kim MJ
    Thromb Res; 2005; 117(1-2):197-200; discussion 201-7. PubMed ID: 16188297
    [No Abstract]   [Full Text] [Related]  

  • 52. Use of FDA-approved drugs in veterinary medicine: prerogatives and responsibilities.
    Mann CJ
    J Am Vet Med Assoc; 1993 May; 202(10):1674-7;discussion 1684-92. PubMed ID: 8514581
    [No Abstract]   [Full Text] [Related]  

  • 53. FDA regulatory compliance reconsidered.
    Tobias C
    Cornell Law Rev; 2008 Jul; 93(5):1003-38. PubMed ID: 18618969
    [No Abstract]   [Full Text] [Related]  

  • 54. Extralabel use of medicated feeds for minor species.
    J Am Vet Med Assoc; 2004 Aug; 225(4):531-2. PubMed ID: 15344358
    [No Abstract]   [Full Text] [Related]  

  • 55. The FDA at work: cutting-edge science promoting public health.
    Hilts PJ
    FDA Consum; 2006; 40(1):28-35, 39-41. PubMed ID: 16528824
    [No Abstract]   [Full Text] [Related]  

  • 56. What's holding up animal drug approval?
    Stribling JH
    J Am Vet Med Assoc; 1992 Jun; 200(12):1806-8. PubMed ID: 1639681
    [No Abstract]   [Full Text] [Related]  

  • 57. Pros and cons of off-label promotion investigations and prosecutions.
    Loucks MK
    Food Drug Law J; 2006; 61(3):577-83. PubMed ID: 16989041
    [No Abstract]   [Full Text] [Related]  

  • 58. Black box warnings in prescription drug labeling: results of a survey of 206 drugs.
    Beach JE; Faich GA; Bormel FG; Sasinowski FJ
    Food Drug Law J; 1998; 53(3):403-11. PubMed ID: 10346718
    [No Abstract]   [Full Text] [Related]  

  • 59. A visit from the FDA.
    Brett J
    J Am Vet Med Assoc; 1994 May; 204(9):1319-20. PubMed ID: 8050959
    [No Abstract]   [Full Text] [Related]  

  • 60. How changes affecting wholesale drug distribution can impact veterinary practitioners.
    Lust E
    J Am Vet Med Assoc; 2008 Oct; 233(7):1081-2. PubMed ID: 18828716
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.